{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:52:48Z","timestamp":1793825568707,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to investigate whether the single nucleotide polymorphism C677T (rs1801133) of the methylene-tetrahydrofolate reductase (MTHFR) gene was associated with the risk of coronary artery disease (CAD) and circulating homocysteine (Hcy) levels in Tunisian population. 310 angiografically diagnosed CAD patients and 210 controls were enrolled in this study. The MTHFR C677T (rs1801133) polymorphism was genotyped, and the Hcy concentrations were measured. The severity of CAD was evaluated using the Gensini scoring system. Compared to the CC genotype, the TT genotype confers a higher risk for CAD severity with an OR\u2009=\u20099.07 and 95% CI\u2009=\u20093.78\u201321.8. The T allele was the predisposing allele for CAD and that it was probably associated with CAD severity. The area under the ROC curve for Hcy was 0.764 (95% CI 0.660 to 0.868, p\u2009=\u20090.001). The receiver operating characteristics curve (ROC) for Hcy showed its useful prediction of CAD. Hcy levels were not significantly associated with CAD severity expressed by Gensini Score (GS). The MTHFR C677T (rs1801133) polymorphism influences circulating Hcy levels. The MTHFR C677T polymorphism and hyperhomocysteinemia could have an important role in the prediction of the presence and not the severity expressed by GS of CAD.<\/jats:p>","DOI":"10.1038\/s41598-020-66937-3","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:03:36Z","timestamp":1592805816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Association of the methylene-tetrahydrofolate reductase gene rs1801133 C677T variant with serum homocysteine levels, and the severity of coronary artery disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Nadia","family":"Bouzidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Hassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajer","family":"Fodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mejdi","family":"Ben Messaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faouzi","family":"Maatouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Gamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Ferchichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"66937_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12872-018-0774-8","volume":"18","author":"CJ Chen","year":"2018","unstructured":"Chen, C. J. et al. Homocysteine is a bystander for ST segment elevation myocardial infarction: a case-control study. BMC Cardiovasc Disord. 18, 33 (2018).","journal-title":"BMC Cardiovasc Disord."},{"key":"66937_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.arr.2018.10.010","volume":"49","author":"EA Ostrakhovitch","year":"2019","unstructured":"Ostrakhovitch, E. A. & Tabibzadeh, S. Homocysteine and age-associated disorders. Ageing Res Rev. 49, 144\u2013164 (2019).","journal-title":"Ageing Res Rev."},{"key":"66937_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.nut.2012.09.015","volume":"29","author":"Agata Chmurzynska","year":"2013","unstructured":"Agata Chmurzynska et al. Elderly women: Homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism). Nutrition 29, 841\u2013844 (2013).","journal-title":"Nutrition"},{"key":"66937_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12944-017-0441-6","volume":"16","author":"M Momin","year":"2017","unstructured":"Momin, M. et al. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids Health Dis. 16, 54 (2017).","journal-title":"Lipids Health Dis."},{"key":"66937_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jcma.2016.07.005","volume":"80","author":"J Ni","year":"2017","unstructured":"Ni, J. et al. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China. J. Chin. Med. Assoc. 80, 147\u2013153 (2017).","journal-title":"J. Chin. Med. Assoc."},{"key":"66937_CR6","doi-asserted-by":"crossref","unstructured":"Jin, W. et al. Association of MTHFR C677T gene polymorphism with metabolic syndrome in a Chinese population: a case\u2013control study. J. Int. Med. Res. 46, 2658\u20132669 (2018).","DOI":"10.1177\/0300060518768969"},{"key":"66937_CR7","doi-asserted-by":"publisher","first-page":"e9044","DOI":"10.1097\/MD.0000000000009044","volume":"96","author":"MN Li","year":"2017","unstructured":"Li, M. N. et al. MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome. Medicine (Baltimore) 96, e9044 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"66937_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12944-018-0837-y","volume":"17","author":"Z Luo","year":"2018","unstructured":"Luo, Z. et al. Associations of the MTHFR rs1801133 polymorphism with coronary artery disease and lipid levels: a systematic review and updated meta-analysis. Lipids Health Dis 17, 191 (2018).","journal-title":"Lipids Health Dis"},{"key":"66937_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00129784-200101050-00005","volume":"1","author":"K Nakai","year":"2001","unstructured":"Nakai, K. et al. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J. Cardiovasc Drugs 1, 353\u2013361 (2001).","journal-title":"Am J. Cardiovasc Drugs"},{"key":"66937_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5758\/vsi.2014.30.4.113","volume":"30","author":"WC Park","year":"2014","unstructured":"Park, W. C. & Chang, J. H. Clinical Implications of Methylenetetrahydrofolate Reductase Mutations and Plasma Homocysteine Levels in Patients with Thromboembolic Occlusion. Vasc Specialist Int 30, 113\u2013119 (2014).","journal-title":"Vasc Specialist Int"},{"key":"66937_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gene.2015.06.044","volume":"571","author":"P Ramkaran","year":"2015","unstructured":"Ramkaran, P. et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with increased risk of coronary artery disease in young South African Indians. Gene 571, 28\u201332 (2015).","journal-title":"Gene"},{"key":"66937_CR12","first-page":"487","volume":"63","author":"Z Jerbi","year":"2005","unstructured":"Jerbi, Z. et al. \u00c9tude du polymorphisme C677T du g\u00e8ne de la m\u00e9thyl\u00e8ne t\u00e9trahydrofolate r\u00e9ductase dans la population tunisienne. Ann Biol. Clin. 63, 487\u2013491 (2005).","journal-title":"Ann Biol. Clin."},{"key":"66937_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1258\/000456306776865232","volume":"43","author":"M Kerkeni","year":"2006","unstructured":"Kerkeni, M. et al. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem. 43, 200\u2013206 (2006).","journal-title":"Ann Clin Biochem."},{"key":"66937_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11239-008-0194-1","volume":"27","author":"L Ghazouani","year":"2009","unstructured":"Ghazouani, L. et al. Homocysteine and methylene-tetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease. J. Thromb Thrombolysis 27, 191\u2013197 (2009).","journal-title":"J. Thromb Thrombolysis"},{"key":"66937_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.gene.2017.02.015","volume":"610","author":"TA Abd El-Aziz","year":"2017","unstructured":"Abd El-Aziz, T. A. & Mohamed, R. H. Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis. Gene 610, 127\u2013132 (2017).","journal-title":"Gene"},{"key":"66937_CR16","first-page":"14853e8","volume":"98","author":"K Yamada","year":"2001","unstructured":"Yamada, K. et al. Effects of common polymorphisms on the properties of recombinant human methylenetetra-hydrofolate reductase. Proc. Natl. Acad. Sci. 98, 14853e8 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"66937_CR17","doi-asserted-by":"publisher","first-page":"9e14","DOI":"10.1016\/j.numecd.2018.09.003","volume":"29","author":"E Cohen","year":"2019","unstructured":"Cohen, E. et al. Gender differences in homocysteine concentrations, a populationbased cross-sectional study. Nutr. Metab. Cardiovasc. Dis. 29, 9e14 (2019).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"66937_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tracli.2019.01.003","volume":"26","author":"BVKS Lakkakula","year":"2019","unstructured":"Lakkakula, B. V. K. S. Association between MTHFR 677C\u2009>\u2009T polymorphism and vascular complications in sickle cell disease: A meta-analysis. Transfus Clin Biol. 26, 284\u2013288 (2019).","journal-title":"Transfus Clin Biol."},{"key":"66937_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clim.2018.02.014","volume":"193","author":"Maira Gianneloua","year":"2018","unstructured":"Maira Gianneloua et al. Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis. Clin Immunol. 193, 110\u2013117 (2018).","journal-title":"Clin Immunol."},{"key":"66937_CR20","first-page":"154","volume":"127","author":"F Rassoul","year":"2008","unstructured":"Rassoul, F. et al. Plasma homocysteine levels and C677T methylenetetra-hydrofolate -reductase gene polymorphism in patients with coronary artery disease of different severity. Indian J. Med. Res. 127, 154\u2013158 (2008).","journal-title":"Indian J. Med. Res."},{"key":"66937_CR21","doi-asserted-by":"publisher","first-page":"e9044","DOI":"10.1097\/MD.0000000000009044","volume":"96","author":"MN Li","year":"2017","unstructured":"Li, M. N. et al. MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome. Medicine. 96, e9044 (2017).","journal-title":"Medicine."},{"key":"66937_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000343356","volume":"31","author":"YG Zhe","year":"2013","unstructured":"Zhe, Y. G. et al. OLR1, PON1 and MTHFR Gene Polymorphisms, Conventional Risk Factors and the Severity of Coronary Atherosclerosis in a Chinese Han Population. Cell. Physiol. Biochem. 31, 143\u2013152 (2013).","journal-title":"Cell. Physiol. Biochem."},{"key":"66937_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12013-012-9483-6","volume":"66","author":"H Xu","year":"2013","unstructured":"Xu, H. et al. Plaque image characteristics, hyperhomocysteinemia, and gene polymorphism of homocysteine metabolism-related enzyme (MTHFR C677T) in acute coronary syndrome. Cell. Biochem. Biophys. 66, 403\u2013407 (2013).","journal-title":"Cell. Biochem. Biophys."},{"key":"66937_CR24","first-page":"321","volume":"9","author":"S Alroy","year":"2007","unstructured":"Alroy, S. et al. Endothelial cell dysfunction in women with cardiac syndrome X and MTHFR C677T mutation. IMAJ 9, 321\u2013325 (2007).","journal-title":"IMAJ"},{"key":"66937_CR25","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/01.CIR.95.8.2032","volume":"95","author":"H Morita","year":"1997","unstructured":"Morita, H. et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95, 2032\u20132036 (1997).","journal-title":"Circulation"},{"key":"66937_CR26","first-page":"402","volume":"18","author":"N Bouzidi","year":"2017","unstructured":"Bouzidi, N. et al. Relationship of activin A levels with clinical presentation, extent, and severity of coronary artery disease. Anatol J. Cardiol. 18, 402\u2013409 (2017).","journal-title":"Anatol J. Cardiol."},{"key":"66937_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini, G. G. A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 51, 606 (1983).","journal-title":"Am. J. Cardiol."},{"key":"66937_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.21873\/invivo.11540","volume":"33","author":"A G\u00fcliz Dirimen","year":"2019","unstructured":"G\u00fcliz Dirimen, A. et al. Characteristics of Coronary Artery Disease Patients Who Have a Polymorphism in the Cholesterol Ester Transfer Protein (CETP) Gene. In Vivo 33, 787\u2013792 (2019).","journal-title":"In Vivo"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66937-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:34:42Z","timestamp":1670312082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66937-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66937"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66937-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"25 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10064"}}